1. Home
  2. ULBI vs NKTX Comparison

ULBI vs NKTX Comparison

Compare ULBI & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULBI
  • NKTX
  • Stock Information
  • Founded
  • ULBI 1990
  • NKTX 2015
  • Country
  • ULBI United States
  • NKTX United States
  • Employees
  • ULBI N/A
  • NKTX N/A
  • Industry
  • ULBI Industrial Machinery/Components
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULBI Miscellaneous
  • NKTX Health Care
  • Exchange
  • ULBI Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • ULBI 135.2M
  • NKTX 123.5M
  • IPO Year
  • ULBI 1992
  • NKTX 2020
  • Fundamental
  • Price
  • ULBI $8.93
  • NKTX $1.67
  • Analyst Decision
  • ULBI Strong Buy
  • NKTX Strong Buy
  • Analyst Count
  • ULBI 1
  • NKTX 6
  • Target Price
  • ULBI $14.00
  • NKTX $14.40
  • AVG Volume (30 Days)
  • ULBI 197.4K
  • NKTX 505.0K
  • Earning Date
  • ULBI 07-24-2025
  • NKTX 08-12-2025
  • Dividend Yield
  • ULBI N/A
  • NKTX N/A
  • EPS Growth
  • ULBI N/A
  • NKTX N/A
  • EPS
  • ULBI 0.31
  • NKTX N/A
  • Revenue
  • ULBI $173,275,000.00
  • NKTX N/A
  • Revenue This Year
  • ULBI $31.30
  • NKTX N/A
  • Revenue Next Year
  • ULBI $6.24
  • NKTX N/A
  • P/E Ratio
  • ULBI $28.49
  • NKTX N/A
  • Revenue Growth
  • ULBI 2.74
  • NKTX N/A
  • 52 Week Low
  • ULBI $4.07
  • NKTX $1.31
  • 52 Week High
  • ULBI $12.40
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • ULBI 64.06
  • NKTX 39.70
  • Support Level
  • ULBI $7.85
  • NKTX $1.70
  • Resistance Level
  • ULBI $8.46
  • NKTX $1.84
  • Average True Range (ATR)
  • ULBI 0.44
  • NKTX 0.09
  • MACD
  • ULBI -0.08
  • NKTX -0.02
  • Stochastic Oscillator
  • ULBI 60.33
  • NKTX 2.38

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: